Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27


Genomic and Phenotypic Variability in Neisseria gonorrhoeae Antimicrobial Susceptibility, England.

Town K, Harris S, Sánchez-Busó L, Cole MJ, Pitt R, Fifer H, Mohammed H, Field N, Hughes G.

Emerg Infect Dis. 2020 Mar;26(3):505-515. doi: 10.3201/eid2603.190732.


Phylogenomic analysis of Neisseria gonorrhoeae transmission to assess sexual mixing and HIV transmission risk in England: a cross-sectional, observational, whole-genome sequencing study.

Town K, Field N, Harris SR, Sánchez-Busó L, Cole MJ, Pitt R, Fifer H, Mohammed H, Hughes G.

Lancet Infect Dis. 2020 Jan 21. pii: S1473-3099(19)30610-3. doi: 10.1016/S1473-3099(19)30610-3. [Epub ahead of print]


Who is coming back for more chlamydia testing within non-specialist health services and where do they go? England, 2013-2016.

Harb AK, Town K, Callan E, Furegato M, Connor N, Dunbar JK.

Public Health. 2019 Dec 31;180:136-140. doi: 10.1016/j.puhe.2019.11.010. [Epub ahead of print]


A novel therapy for an unusual problem: IL-1 receptor antagonist for recurrent post-transplant pericarditis.

Parizo JT, Moayedi Y, Nieman K, Town K, Teuteberg JJ, Khush KK.

Clin Transplant. 2019 Oct;33(10):e13699. doi: 10.1111/ctr.13699. Epub 2019 Sep 8.


Detection of tet(M) in high-level tetracycline-resistant Neisseria gonorrhoeae.

Pitt R, Sadouki Z, Town K, Fifer H, Mohammed H, Hughes G, Woodford N, Cole MJ.

J Antimicrob Chemother. 2019 Jul 1;74(7):2115-2116. doi: 10.1093/jac/dkz130. No abstract available.


Detection in the United Kingdom of the Neisseria gonorrhoeae FC428 clone, with ceftriaxone resistance and intermediate resistance to azithromycin, October to December 2018.

Eyre DW, Town K, Street T, Barker L, Sanderson N, Cole MJ, Mohammed H, Pitt R, Gobin M, Irish C, Gardiner D, Sedgwick J, Beck C, Saunders J, Turbitt D, Cook C, Phin N, Nathan B, Horner P, Fifer H.

Euro Surveill. 2019 Mar;24(10). doi: 10.2807/1560-7917.ES.2019.24.10.1900147.


Qualitative impact assessment of an educational workshop on primary care practitioner attitudes to NICE HIV testing guidelines.

Allison RL, Ricketts EJ, Hartney T, Nardone A, Town K, Rugman C, Folkard K, Dunbar JK, McNulty CA.

BJGP Open. 2018 Apr 7;2(1):bjgpopen18X101433. doi: 10.3399/bjgpopen18X101433. eCollection 2018 Apr.


Neisseria gonorrhoeae molecular typing for understanding sexual networks and antimicrobial resistance transmission: A systematic review.

Town K, Bolt H, Croxford S, Cole M, Harris S, Field N, Hughes G.

J Infect. 2018 Jun;76(6):507-514. doi: 10.1016/j.jinf.2018.02.011. Epub 2018 Apr 24.


Is previous azithromycin treatment associated with azithromycin resistance in Neisseria gonorrhoeae? A cross-sectional study using national surveillance data in England.

Clifton S, Town K, Furegato M, Cole M, Mohammed H, Woodhall SC, Kevin Dunbar J, Fifer H, Hughes G.

Sex Transm Infect. 2018 Sep;94(6):421-426. doi: 10.1136/sextrans-2017-053461. Epub 2018 Mar 6.


Considering the Potential Application of Whole Genome Sequencing to Gonorrhea Prevention and Control.

Kirkcaldy RD, Town K, Gernert KM, Bowen VB, Torrone EA, Kersh EN, Bernstein KT.

Sex Transm Dis. 2018 Jun;45(6):e29-e32. doi: 10.1097/OLQ.0000000000000813. No abstract available.


Linkage to HIV care following diagnosis in the WHO European Region: A systematic review and meta-analysis, 2006-2017.

Croxford S, Yin Z, Burns F, Copas A, Town K, Desai S, Skingsley A, Delpech V; OptTEST project.

PLoS One. 2018 Feb 16;13(2):e0192403. doi: 10.1371/journal.pone.0192403. eCollection 2018. Review.


Detection of Chlamydia trachomatis in rectal specimens in women and its association with anal intercourse: a systematic review and meta-analysis.

Chandra NL, Broad C, Folkard K, Town K, Harding-Esch EM, Woodhall SC, Saunders JM, Sadiq ST, Dunbar JK.

Sex Transm Infect. 2018 Aug;94(5):320-326. doi: 10.1136/sextrans-2017-053161. Epub 2018 Feb 3.


Prevalence of and factors associated with MDR Neisseria gonorrhoeae in England and Wales between 2004 and 2015: analysis of annual cross-sectional surveillance surveys.

Clifton S, Bolt H, Mohammed H, Town K, Furegato M, Cole M, Campbell O, Fifer H, Hughes G.

J Antimicrob Chemother. 2018 Apr 1;73(4):923-932. doi: 10.1093/jac/dkx520.


Qualitative interviews with healthcare staff in four European countries to inform adaptation of an intervention to increase chlamydia testing.

McNulty C, Ricketts EJ, Fredlund H, Uusküla A, Town K, Rugman C, Tisler-Sala A, Mani A, Dunais B, Folkard K, Allison R, Touboul P.

BMJ Open. 2017 Sep 25;7(9):e017528. doi: 10.1136/bmjopen-2017-017528.


Chlamydia and HIV testing, contraception advice, and free condoms offered in general practice: a qualitative interview study of young adults' perceptions of this initiative.

Jones LF, Ricketts E, Town K, Rugman C, Lecky D, Folkard K, Nardone A, Hartney TN, McNulty C.

Br J Gen Pract. 2017 Jul;67(660):e490-e500. doi: 10.3399/bjgp17X691325. Epub 2017 May 22.


Exploring why a complex intervention piloted in general practices did not result in an increase in chlamydia screening and diagnosis: a qualitative evaluation using the fidelity of implementation model.

Allison R, Lecky DM, Town K, Rugman C, Ricketts EJ, Ockendon-Powell N, Folkard KA, Dunbar JK, McNulty CA.

BMC Fam Pract. 2017 Mar 21;18(1):43. doi: 10.1186/s12875-017-0618-0.


Estimating gonorrhoea prevalence in young heterosexual men and women attending community-based sexual health services to inform decisions on gonorrhoea testing.

Town K, Furegato M, Field N, Hughes G.

Epidemiol Infect. 2017 Jun;145(8):1682-1687. doi: 10.1017/S0950268817000024. Epub 2017 Mar 3.


Service evaluation of an educational intervention to improve sexual health services in primary care implemented using a step-wedge design: analysis of chlamydia testing and diagnosis rate changes.

Town K, McNulty CA, Ricketts EJ, Hartney T, Nardone A, Folkard KA, Charlett A, Dunbar JK.

BMC Public Health. 2016 Aug 2;16:686. doi: 10.1186/s12889-016-3343-z.


Drifting towards ceftriaxone treatment failure in gonorrhoea: risk factor analysis of data from the Gonococcal Resistance to Antimicrobials Surveillance Programme in England and Wales.

Town K, Obi C, Quaye N, Chisholm S, Hughes G; GRASP Collaborative Group.

Sex Transm Infect. 2017 Feb;93(1):39-45. doi: 10.1136/sextrans-2016-052583. Epub 2016 Jul 5.


Supporting general practices to provide sexual and reproductive health services: protocol for the 3Cs & HIV programme.

Town K, Ricketts EJ, Hartney T, Dunbar JK, Nardone A, Folkard KA, Charlett A, McNulty CA.

Public Health. 2015 Sep;129(9):1244-50. doi: 10.1016/j.puhe.2015.07.016. Epub 2015 Aug 13.


Risk factors for antimicrobial-resistant Neisseria gonorrhoeae in Europe.

Cole MJ, Spiteri G, Town K, Unemo M, Hoffmann S, Chisholm SA, Amato-Gauci AJ, van de Laar M, Ison CA; Euro-GASP Network.

Sex Transm Dis. 2014 Dec;41(12):723-9. doi: 10.1097/OLQ.0000000000000185.


Can previous first-line therapies for Neisseria gonorrhoeae be targeted to specific patient subgroups to treat gonorrhea?

Town K, Lowndes CM, Hughes G, Obi C, Chisholm S, Ison CA; GRASP collaborative group.

Sex Transm Dis. 2015 Jan;42(1):37-42. doi: 10.1097/OLQ.0000000000000223.


A survey of the use of text messaging for communication with partners in the process of provider-led partner notification.

Gilbart VL, Town K, Lowndes CM.

Sex Transm Infect. 2015 Mar;91(2):97-9. doi: 10.1136/sextrans-2014-051701. Epub 2014 Oct 28.


Screening for gonorrhoea using samples collected through the English national chlamydia screening programme and risk of false positives: a national survey of local authorities.

Field N, Kennedy I, Folkard K, Duffell S, Town K, Ison CA, Hughes G.

BMJ Open. 2014 Oct 16;4(10):e006067. doi: 10.1136/bmjopen-2014-006067.


Decreased susceptibility to cephalosporins among gonococci? Authors' reply.

Ison CA, Town K, Obi C, Chisholm S, Hughes G, Livermore DM, Lowndes CM.

Lancet Infect Dis. 2014 Mar;14(3):186-7. doi: 10.1016/S1473-3099(14)70023-4. No abstract available.


Decreased susceptibility to cephalosporins among gonococci: data from the Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) in England and Wales, 2007-2011.

Ison CA, Town K, Obi C, Chisholm S, Hughes G, Livermore DM, Lowndes CM; GRASP collaborative group.

Lancet Infect Dis. 2013 Sep;13(9):762-8. doi: 10.1016/S1473-3099(13)70143-9. Epub 2013 Jun 11.


Supplemental Content

Support Center